[ad_1]
A COMMON rheumatoid arthritis drug could hold the key to lowering blood glucose levels in patients with Type 2 diabetes, says a study. Scientists have discovered that the anti-inflammatory drug leflunomide has highly beneficial effects on diabetes sufferers.
[ad_2]
Read More
